A business in context
PVLA research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-16 | Goin Kathleen | S · Sale | Common Stock | 1654.0 | 153.24 |
| 2026-09-16 | Goin Kathleen | S · Sale | Common Stock | 989.0 | 152.36 |
| 2026-09-16 | Goin Kathleen | S · Sale | Common Stock | 1659.0 | 151.16 |
| 2026-09-16 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2154.0 | 7.14 |
| 2026-09-16 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2148.0 | 9.08 |
| 2026-09-16 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2148.0 | 0.0 |
| 2026-09-16 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2154.0 | 0.0 |
| 2026-09-15 | JENKINS GEORGE M | S · Sale | Common Stock | 560.0 | 151.33 |
| 2026-09-15 | JENKINS GEORGE M | S · Sale | Common Stock | 954.0 | 149.38 |
| 2026-09-15 | JENKINS GEORGE M | S · Sale | Common Stock | 263.0 | 150.4 |
| 2026-09-14 | JENKINS GEORGE M | S · Sale | Common Stock | 5632.0 | 151.46 |
| 2026-09-14 | JENKINS GEORGE M | S · Sale | Common Stock | 6160.0 | 152.12 |
| 2026-09-14 | JENKINS GEORGE M | S · Sale | Common Stock | 1560.0 | 153.1 |
| 2026-09-11 | JENKINS GEORGE M | S · Sale | Common Stock | 1274.0 | 153.06 |
| 2026-09-11 | JENKINS GEORGE M | S · Sale | Common Stock | 4577.0 | 151.72 |
| 2026-09-11 | JENKINS GEORGE M | S · Sale | Common Stock | 6520.0 | 150.62 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | M · Exercise / conversion | Common Stock | 313.0 | 127.2 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | S · Sale | Common Stock | 313.0 | 157.0 |
| 2026-09-02 | KIRITSY CHRISTOPHER P | M · Exercise / conversion | Stock Option (Right to Buy) | 313.0 | 0.0 |
| 2026-08-19 | Goin Kathleen | S · Sale | Common Stock | 102.0 | 155.59 |
| 2026-08-19 | Goin Kathleen | S · Sale | Common Stock | 400.0 | 153.0 |
| 2026-08-19 | Goin Kathleen | S · Sale | Common Stock | 1998.0 | 151.8 |
| 2026-08-19 | Goin Kathleen | S · Sale | Common Stock | 1500.0 | 151.39 |
| 2026-08-19 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2148.0 | 9.08 |
| 2026-08-19 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2154.0 | 7.14 |
| 2026-08-19 | Goin Kathleen | S · Sale | Common Stock | 302.0 | 156.77 |
| 2026-08-19 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2154.0 | 0.0 |
| 2026-08-19 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2148.0 | 0.0 |
| 2026-07-15 | Goin Kathleen | S · Sale | Common Stock | 1911.0 | 150.25 |
| 2026-07-15 | Goin Kathleen | S · Sale | Common Stock | 1029.0 | 149.27 |
| 2026-07-15 | Goin Kathleen | S · Sale | Common Stock | 840.0 | 148.4 |
| 2026-07-15 | Goin Kathleen | S · Sale | Common Stock | 522.0 | 147.14 |
| 2026-07-15 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2148.0 | 9.08 |
| 2026-07-15 | Goin Kathleen | M · Exercise / conversion | Common Stock | 2154.0 | 7.14 |
| 2026-07-15 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2148.0 | 0.0 |
| 2026-07-15 | Goin Kathleen | M · Exercise / conversion | Stock Option (Right to Buy) | 2154.0 | 0.0 |
| 2026-06-29 | Pauls Matthew | A · Grant / award | Stock Option (Right to Buy) | 6000.0 | 0.0 |
Identity & relationships
SEC issuer · 0001583648PALVELLA THERAPEUTICS, INC.
Search names and former names
- PIERIS PHARMACEUTICALS, INC. · former SEC name · 2014-12-23 to 2024-12-12
- Marika Inc. · former SEC name · 2013-08-20 to 2014-12-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2023-12-31 | $42.81M | $47.34M |
| 2022-12-31 | $25.90M | $29.82M |
| 2021-12-31 | $31.42M | $39.06M |
| 2020-12-31 | $29.32M | $38.17M |
| 2019-12-31 | $46.28M | $60.99M |
| 2018-12-31 | $29.10M | $39.05M |
| 2017-12-31 | $25.27M | $34.74M |